Skip to main content
Erschienen in: BMC Infectious Diseases 1/2011

Open Access 01.12.2011 | Research article

The occupational risk of Helicobacter pyloriinfection among gastroenterologists and their assistants

verfasst von: Claudia Peters, Anja Schablon, Melanie Harling, Claudia Wohlert, José Torres Costa, Albert Nienhaus

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2011

Abstract

Background

Helicobacter pylori is a widely spread bacterium that mainly inhabits the gastric mucosa and can lead to serious illnesses such as peptic ulcer disease, gastric carcinoma and gastric MALT lymphoma. The oral-oral route seems to be the main transmission route. The fact that endoscopes are contaminated after being used to perform a gastroscopy leads one to question whether gastroenterologists and endoscopy nurses and assistants run a higher risk of infection.

Methods

A systematic search for literature was conducted in the MEDLINE and EMBASE databases and further publications were found in reference lists of relevant articles. Epidemiological studies on the occupational exposure of endoscopy personnel were collected and their quality was assessed. Pooled effect estimates were identified in a meta-analysis.

Results

Of the 24 studies included in the analysis, 15 were considered to be methodologically good. Of these 15 studies, eight single studies showed a statistically significant increased risk of infection for gastroenterologists, and five for their assistants. Meta-analysis across all methodologically good studies found a statistically significant risk of 1.6 (95%CI 1.3-2.0) for doctors. The pooled effect estimates also indicated a statistically significant risk of Helicobacter pylori infection (RR 1.4; 95%CI 1.1-1.8) for assistants too.
When studies are stratified by medical and non-medical control groups, statistically significant risks can only be recognised in the comparison with non-medical controls.

Conclusions

In summary, our results demonstrated an increased risk of Helicobacter pylori infection among gastroenterological personnel. However, the choice of control group is important for making a valid assessment of occupational exposure risks.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2334-11-154) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

AS made substantial contributions to the design of the study and to the extraction and interpretation of data. She was involved in the drafting of the major scientific content in the manuscript. MH made substantial contributions to the analysis and interpretation of the data. She was involved in proofreading and editing the scientific content of the manuscript. CW made substantial contributions to the design of the study. She was involved in proofreading and editing the scientific content of the manuscript. JTC made substantial contributions to the interpretation of data and was involved in revising the manuscript critically for important intellectual content. AN made substantial contributions to the design and to the extraction and interpretation of data. He was involved in drafting the manuscript. CP made substantial contributions to the design of the study, the extraction of data, and to the analysis and interpretation of data. She was involved in drafting the manuscript. All authors confirm that they have seen and approved the final version and have no conflicts of interest.

Background

Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped bacterium that mainly inhabits and multiplies in the gastric mucosa [1, 2]. The bacterium produces the enzyme urease and this convert urea into carbon dioxide and ammonia. The ammonium envelope enables it to resist the acidic environment in the stomach [1]. The prevalence of H. pylori varies widely from region to region, with an especially marked difference between industrial and developing countries. The estimated prevalence in Asia is 50 to 80%, 30 to 50% in Western Europe and 30% in North America [3]. In Germany, the prevalence of H. pylori infections among the population is between 20 and 70% [4]. Within the framework of the German National Health Inverview and Examination Survey 1998 a 40% prevalence of H. pylori antibodies among the general population was found. In the youngest age group (aged 18 to 29) the prevalence was 22%, while in the oldest age group it was 61%. In the low socioeconomic status group, the prevalence was 51%, whereas it was 29% in the upper class [4]. There is a positive correlation between the number of persons in a household and the rate of H. pylori infection [5].
H. pylori is associated with peptic ulcer disease, distal gastric carcinoma and gastric MALT lymphoma [1]. It has long been known that the stomach harbours a population of bacteria [1], but not until Marshall and Warren's work in 1984 [6] was the link between Campylobacter pyloridis, as H. pylori was then known, and chronic gastritis appreciated, which "revolutionised the understanding of pathological gastric processes" [1]. Individuals infected with H. pylori run a three times greater risk of contracting an ulcus ventriculi and a two and a half times greater risk of developing adenocarcinoma of the stomach [7]. There also appears to be a synergistic carcinogenic effect when smoking and H. pylori infections are combined [8].
The transmission routes of H. pylori have yet to be fully explained [1, 4, 6]. The likelihood of infection increases with low social status and the associated crowded living conditions. The infection is mainly acquired in childhood [9]. H. pylori has been isolated from faeces [10], gastric juice, vomit, saliva and dental plaque [11, 12]. It is transmitted from person to person. The oral-oral route seems to be the main route of transmission. Contact with regurgitated matter seems to play a more important role in transmission than contact with saliva, since promiscuity is not a transmission risk factor [2, 7] and transmission between married couples is rare [13]. Dentists come into close contact with their patients' saliva, but although they have been found to be at greater risk [14], there is insufficient evidence of an increased risk of infection [15, 16]. There are reports of a high prevalence of H. pylori infections in institutions for people with intellectual disability. Health care workers working in these institutions are especially vulnerable because of their close contact [17].
H. pylori inhabits the gastric mucosa. Consequently, the endoscopes used to perform gastroscopies on patients affected become contaminated. Infection can be passed on to other patients via these endoscopes. The first recorded nosocomial infection with H. pylori was reported in 1979. 17 of 37 healthy subjects who took part in a study on acid concentrations in the stomach developed gastritis after an endoscopy [18]. Although, appropriate decontamination can certainly prevent transmission via this route [18, 19]. Given that the oral-oral route seems to be the predominant way of transmitting H. pylori, the question is whether doctors who perform gastroscopies, or the nurses who assist them, run an increased risk of infection. Several reviews have been published, but some data were controversial. We therefore checked the literature and conducted a meta-analysis to determine the occupational risk of H. pylori infection among gastroenterological personnel.

Methods

Search strategy and screening

For the literature search, we first considered the studies published in three review articles published in 1999 [20], 2001 [21] and 2004 [22]. This work was supplemented by a systematic search for literature in the MEDLINE and EMBASE databases using appropriate keywords - "Helicobacter pylori" combined with "occupational risk, endoscopy, gastroenterologist, healthcare worker" - for the years 1999 to 2010. We also searched through the reference lists of the chosen studies and included appropriate publications in our work.
The criteria for inclusion related to the following:
Study design: cohort study or cross-sectional study
Study population: the study investigates gastroenterologists and/or their assistants (nurses)
Exposure: the study investigates occupation as a risk factor
Languages: German and English

Study quality

The methodological quality of the studies was assessed as moderate or good. A study was categorised as moderate if it did not take into account the potential confounding effect of age and socioeconomic status or did not adequately describe the control group's origin in order to check for the potential of confounding. Very small studies with fewer than 30 subjects per group also counted as methodologically moderate. Three authors carried out the literature screening and quality evaluation independently from one other and then compared their findings. Where they disagreed, a consensus was reached by means of discussion.

Statistical analysis

The studies are differentiated into prospective incidence studies and retrospective prevalence studies. For the purposes of statistical analysis, we used the information on the number of gastroenterological personnel and the control group as a whole, and the proportion in each case that had tested positive for H. pylori. This data was used to calculate prevalence ratios as effect estimates in the case of retrospective original studies. These are described as relative risks (RR). 95% confidence intervals (95%CI) were generated to serve as statistical tests. For the purpose of meta-analysis, a combined effect estimate was calculated using the Mantel-Haenszel method for dichotomous outcomes. Stratification enabled us to conduct further differentiated analyses relating to individual occupational groups, the kind of controls, the study region and the time of publication.

Heterogeneity

We carried out a chi-square test (χ2) in order to examine the statistical heterogeneity between studies. If there was statistically significant heterogeneity (P < 0.05) the random effect model was used to calculate the combined effect estimate, otherwise the fixed effect method was used.

Sensitivity analysis

The impact of the studies on the combined effect estimate finding was tested by excluding individual studies from the analysis and examining the estimate stability [23]. The quality of the studies was also compared in this context. Where there is a clearly recognisable difference, the moderate studies can be considered separately or excluded from the analysis.

Publication bias

We first showed a possible publication bias graphically using a funnel plot. The effect estimate was plotted versus the precision of the estimate (defined as the inverse of standard error (1/SEi)). An asymmetry of this funnel plot indicates publication bias. The funnel plot asymmetry was additionally measured following a linear regression approach on the natural logarithmic scale of the effect estimate. In this method, the standard normal deviate, defined as the effect estimate divided by its standard error, is regressed against the precision. The intercept provides a measure of asymmetry. The greater the deviation from zero, the stronger the evidence of asymmetry [24].
The analyses were carried out using Review Manager (RevMan 5) and Microsoft Excel.

Results

Studies identified and assessment of study quality

24 studies [2548] dealing with occupational exposure to H. pylori among gastroenterologists and their colleagues were identified and included in our meta-analysis. The individual studies are listed in Tables 1 and 2. In the main, the study design is cross-sectional, so prevalence ratios are stated. The study by Hildebrand [27] is an exception. Here, the longitudinal design enables the authors to show incidence as well as prevalence. Thus, an incidence of 2.6% per year was found among gastroenterologists and an incidence of 0.14% per year among the control group. However, only retrospective prevalence analyses were taken into account in the meta-analysis.
Table 1
Information, risk estimation and quality assessment of studies with non-medical controls
First author, year
Study area
Gastros
(HP positive %)
Controls
(HP positive %)
Diagnostic
method
RR
95%CI
Study
quality
Mastromarino 2005 [25]
Italy
S 92 (40)
D 47 (34)
A 45 (37)
52 (19) hosp
Stool antigen test
S 1.9
D 1.8
A 2.1
1.04-3. 6
0.9-3.5
1.1-4.0
good
Birkenfeld 2004 [26]
Israel
S 190 (73)
D 88 (72)
A 50 (53)
4633 (53) pat
Breath test
S 1.8
D 1.4
A 1.5
1.3-1.5
1.2-1.5
1.3-1.7
good
Hildebrand 2000 [27]
Switzerland
D 92 (39)
168 (38) pop
Breath test
D 1.03
0.8-1.4
good
Ellett 1999 [28]
USA
A 138 (14)
112 (18) don
Serology
A 0.8
0.4-1.4
good
Monés 1999 [29]
Spain
D 137 (53)
189 (52) pop
Breath test
D 1.03
0.8-1.3
good
Abbas 1998 [30]
Pakistan
S 33 (79)
D 19 (68)
A 14 (93)
33 (58)
neighbours
Serology
S 1.4
D 1.2
A 1.6
0.97-1.9
0.8-1.8
1.2-2.2
good
Nishikawa 1998 [31]
Japan
S 121 (30)
D 92 (30)
A 29 (28)
101 (25) pop
Serology
S 1.2
D 1.2
A 1.1
0.8-1.9
0.8-2.0
0.6-2.2
good
Braden 1997 [32]
Germany
S 1091 (38)
D 922 (38)
A 169 (37)
413 (27) pop
Breath test
S 1.4
D 1.4
A 1.4
1.2-1.7
1.2-1.7
1.1-1.7
good
Goh 1996 [33]
Malaysia
S 82 (33)
D 34 (41)
A 48 (27)
53 (11) pop
Breath test
S 2.9
D 3.6
A 2.4
1.3-6.6
1.6-8.5
0.99-5.8
good
Liu 1996 [34]
China
S 170 (81)
D 125 (82)
A 45 (78)
702 (45) pop
Serology
S 1.8
D 1.9
A 1.7
1.6-2.0
1.7-2.1
1.5-2.1
good
Chong 1994 [35]
USA
S 122 (53)
D 111 (52)
A 11 (52)
510 (14) don
Serology
S 3.8
D 3.7
A 3.9
2.9-5.0
2.8-4.9
2.2-6.9
good
Lin 1994 [36]
Australia
D 39 (69)
A 107 (17)
195 (37) pop
115 (37) pop
Serology
D 1.9
A 0.6
1.4-2.5
0.4-1.01
good
Velasco 2007 [37]
Cuba
S 38 (39)
38 (8) hosp
Serology
S 5.0
1.6-15.9
moderate
Prónai 2000 [38]
Hungary
D 101 (30)
426 (54) pop
Breath test
D 0.6
0.4-0.8
moderate
Kamat 1999 [39]
India
D 17 (29)
35 (20) hosp
Serology
D 1.5
0.6-4.0
moderate
Rudi 1997 [40]
Germany
S 75 (24)
110 (35) hosp
Serology
S 0.7
0.4-1.1
moderate
Pristautz 1994 [41]
Austria
D 88 (57)
100 (51) pop+don
Serology
D 1.1
0.9-1.5
moderate
Mitchel 1989 [42]
Australia
S 101 (30)
D 33 (51)
A 68 (19)
715 (22) don
Serology
S 1.4
D 2.4
A 0.9
0.99-1.9
1.7-3.4
0.5-1.5
moderate
Reiff 1989 [43]
Germany
S 45 (69)
165 (65)
stud+don+pat
Serology
S 1.1
0.9-1.3
moderate
Rawles 1987 [44]
USA
S 38 (32)
20 (10) don
Serology
S 3.2
0.8-12.8
moderate
Morris 1986 [45]
New Zealand
S 36 (25)
D 21 (33)
A 11 (18)
261 (37) pop
Serology
S 0.7
D 0.9
A 0.5
0.4-1.2
0.5-1.7
0.1-1.8
moderate
Gastros = gastroenterological staff
S = staff, D = doctors, A = assistants, don = blood donors, pat = patients, stud = students
hosp = hospital staff = without contact with patients or not defined
med = medical staff = in contact with patients
Table 2
Information, risk estimation and quality assessment of studies with medical controls
First author, year
Study area
Gastros
(HP positive %)
Controls
(HP positive %)
Diagnostic
method
RR
95%CI
Study
quality
Noone 2006 [46]
Scotland
A 74 (32)
148 (33)
Serology
A 0.98
0.7-1.5
good
Mastromarino 2005 [25]
Italy
S 92 (40)
D 47 (34)
A 45 (37)
105 (35)
Stool antigen test
S 1.05
D 0.97
A 1.1
0.7-1.5
0.6-1.6
0.7-1.8
good
Birkenfeld 2004 [26]
Israel
S 190 (73)
D 88 (72)
A 50 (53)
98 (70)
Breath test
S 1.02
D 1.00
A 1.02
0.9-1.2
0.9-1.2
0.8-1.3
good
Monés 1999 [29]
Spain
D 137 (53)
44 (50)
Breath test
D 1.07
0.8-1.3
good
Potts 1997 [47]
England/Wales
D 30 (50)
30 (10)
Breath test
D 5.0
1.6-15.5
good
Braden 1997 [32]
Germany
S 1091 (38)
D 922 (38)
A 169 (37)
604 (36)
Breath test
S 1.05
D 1.06
A 1.02
0.9-1.2
0.9-1.2
0.8-1.3
good
Su 1996 [48]
Taiwan
D 70 (80)
64 (52)
Serology
D 1.6
1.2-2.0
good
Goh 1996 [33]
Malaysia
S 82 (33)
D 34 (41)
A 48 (27)
25 (12)
Breath test
S 2.74
D 3.4
A 2.3
0.9-8.3
1.1-10.7
0.7-7.2
good
Prónai 2000 [38]
Hungary
D 101 (30)
108 (35)
Breath test
D 0.8
0.6-1.3
moderate
Kamat 1999 [39]
India
D 17 (29)
17 (18)
Serology
D 1.7
0.5-5.9
moderate
Rudi 1997 [40]
Germany
S 75 (24)
272 (35)
Serology
S 0.7
0.5-1.1
moderate
Mitchel 1989 [42]
Australia
S 101 (30)
D 33 (51)
A 68 (19)
35 (29)
Serology
S 1.04
D 1.8
A 0.7
0.6-1.9
0.97-3.4
0.3-1.4
moderate
Gastros = gastroenterological staff
S = staff, D = doctors, A = assistants
When study quality was assessed on the basis of the abovementioned criteria, 15 studies were categorised as good [2536, 4648], and nine as methodologically moderate [3745].

Meta-analysis

Pooled analysis of all 24 studies included showed that gastroenterological staff (RR 1.34; 95%CI 1.14-1.58) exhibited a significantly increased risk of H. pylori infection. Pooling of all methodologically good studies confirmed this increased risk (RR 1.52; 95%CI 1.27-1.81), whereas the methodologically moderate studies provided no evidence of higher risk.
A differentiated analysis of the studies, which drew a difference between the information on gastroenterologists, their nurses/assistants and gastroenterological personnel in general, produced a similar picture. While the studies as a whole and the methodologically good studies (Figure 1) showed statistically significant results, the moderate studies showed no difference in H. pylori prevalence between gastroenterological personnel and the controls (Table 3).
Table 3
Summary of findings: Meta-analysis of H. pylori in gastroenterological personnel
 
Number
Pooled estimation
Homogeneity
 
studies
RR
95% CI
χ²
p value
All studies
All
24
1.34
1.14-1.58
174.51
< 0.00001
Staff
14
1.51
1.23-1.84
97.54
< 0.00001
Doctors
18
1.48
1.22-1.81
145.34
< 0.00001
Assistants
13
1.33
1.06-1.66
53.14
< 0.00001
Good studies
All
15
1.52
1.27-1.81
100.00
< 0.00001
Staff
8
1.75
1.39-2.20
62.49
< 0.00001
Doctors
13
1.62
1.33-1.97
85.69
< 0.00001
Assistants
11
1.41
1.13-1.77
43.57
< 0.00001
Moderate studies
All
9
1.04
0.77-1.41
34.13
< 0.00001
Staff
6
1.16
0.79-1.69
17.38
0.004
Doctors
5
1.12
0.62-2.03
41.25
< 0.00001
Assistants
2
0.80
0.50-1.28
0.72
0.4*
Medical controls
Staff
6
1.02
0.90-1.15
6.30
0.28*
   good studies
4
1.06
0.96-1.18
3.17
0.37*
Doctors
10
1.20
0.99-1.45
23.58
0.005
   good studies
7
1.21
0.98-1.50
19.00
0.004
Assistants
6
1.04
0.91-1.20
3.66
0.6*
   good studies
5
1.07
0.93-1.23
2.06
0.73*
Non-medical controls
Staff
14
1.51
1.23-1.84
97.54
< 0.00001
   good studies
8
1.77
1.40-2.23
63.90
< 0.00001
Doctors
16
1.41
1.13-1.77
159.35
< 0.00001
   good studies
11
1.55
1.22-1.96
100.13
< 0.00001
Assistants
12
1.37
1.08-1.73
48.13
< 0.00001
   good studies
10
1.47
1.17-1.85
37.89
< 0.00001
Study area Europe
Staff
4
1.16
0.85-1.59
11.91
0.008
   good studies
2
1.43
1.21-1.69
0.97
0.33*
Doctors
7
1.13
0.85-1.51
35.73
< 0.00001
   good studies
5
1.30
0.99-1.72
13.60
0.009
Assistants
3
    
   good studies
 
1.30
1.06-1.59
3.95
0.14*
Study area Asia
Staff
     
   good studies
5
1.53
1.24-1.89
19.33
0.0007
Doctors
7
1.53
1.26-1.86
18.97
0.004
   good studies
6
1.54
1.26-1.88
18.94
0.002
Assistants
     
   good studies
5
1.58
1.40-1.78
3.97
0.41*
Study area America / Australia
Staff (1 good,5 moderate)
     
 
6
2.07
0.98-4.40
41.01
< 0.00001
Doctors
4
2.08
1.30-3.34
21.65
< 0.00001
   good studies
2
2.63
1.34-5.20)
11.93
0.0006
Assistants
5
0.99
0.47-2.10
29.24
< 0.00001
   good studies
3
1.21
0.36-4.03
28.02
< 0.00001
Diagnostic method: breath test
Staff
3
1.41
1.22-1.63
3.46
< 0.00001
Doctors
7
1.23
0.92-1.64
46.31
< 0.00001
Assistants
3
1.45
1.24-1.69
1.55
0.46*
Diagnostic method: serology
Staff
10
1.47
1.07-2.04
84.87
< 0.00001
Doctors
11
1.66
1.33-2.09
53.62
< 0.00001
Assistants
9
1.17
0.79-1.73
57.54
< 0.00001
Publication date ≤ 1989
Staff
4
1.14
0.94-1.38
6.67
0.08*
Doctors
2
1.30
0.33-5.05
15.56
< 0.00001
Assistants
2
0.80
0.50-1.28
0.72
0.4*
Publication date 1990 - 1999
Staff
7
1.62
1.17-2.24
61.13
< 0.00001
Doctors
12
1.66
1.32-2.08
80.05
< 0.00001
Assistants
8
1.42
1.02-1.98
38.77
< 0.00001
Publication date ≥ 2000
Staff
3
1.93
1.05-3.54
6.87
0.03
Doctors
4
1.04
0.62-1.76
36.22
< 0.00001
Assistants
3
1.36
1.15-1.61
5.19
0.07*
* Fixed effect model
The studies chose to use different control groups, recruiting them either directly from the population at large or non-medical fields ( = without contact with patients, Table 1), or from hospital staff from other departments ( = in contact with patients, Table 2). When the studies are stratified by non-medical controls, pooled analysis showed statistically significant risks for all personnel (RR 1.74; 95%CI 1.23-2.48), for doctors (RR 1.39; 95%CI 1.09-1.77) and for nurses/assistants (RR 1.37; 95%CI 1.08-1.74). In contrast, comparison with medical controls revealed no statistically significant risks.
When the studies were differentiated by location in Europe, Asia and America/Australia, studies conducted in Asia showed a marked 50% increase in risk for all occupational groups in gastroenterological departments. Assistants were the only group observed in the European studies to be at significantly higher risk statistically, whereas doctors were at significantly higher risk in America/Australia. If only methodologically good studies are considered, there is no change in the Asian studies, whereas in Europe a statistically significant increase in risk for all personnel can be seen.
Stratification by method of diagnosis revealed no striking differences between breath test diagnosis and diagnosis by serological examination. Stratification by date of publication showed significantly higher risks for the period 1990-1999 in all groups statistically, while no increase in risk could be seen prior to 1990. For studies published in 2000 or later, statistically significant risks could be seen for endoscopy personnel in general, and for nurses/assistants.

Heterogeneity and sensitivity analysis

Testing for homogeneity revealed clear evidence of heterogeneity among most studies included in this paper. Accordingly, the random effect model was used to calculate the pooled effect estimate. A sensitivity analysis was also carried out, excluding individual studies from the meta-analysis one by one so as to show their influence on the pooled effect estimate. The relative risks thus calculated ranged from 1.26 to 1.40 and were all statistically significant.

Publication Bias

The funnel plot showed no evidence of a marked publication bias (funnel plot not shown), nor did linear regression reveal any significant funnel plot asymmetry (intercept 0.59; 95%CI -1.95-1.83).

Discussion

Pooled analysis of 24 retrospective prevalence studies revealed a higher risk of H. pylori infections among endoscopy personnel, which was statistically significant. This risk is evident for gastroenterologists and for their assistants. The composition of the control group was also found to have a considerable impact. The inclusion of controls that were from the general population or were at least non-medical highlighted significant differences in H. pylori prevalence. On the other hand, comparison with medical controls whose occupational exposure was characterised by contact with patients failed to confirm an increased risk for gastroenterological personnel.
Methodologically good studies were more likely to show statistically significant risks than studies of moderate quality. The use of inadequate controls or insufficient adjustment for confounders like age and socioeconomic status seemingly diluted the effect estimates in studies with moderate quality.

Study area

With respect to the study area, the question arises why the results showed clear levels of significance only in Asia, and not in Europe or America/Australia. The number of studies and their populations cannot account for this, given that more gastroenterological personnel were examined in Europe than in Asia (Table 4). Nor can the quality of studies be sufficient reason for this difference, although stratification by study quality did reveal larger effect estimates in methodologically good studies than in those with moderate quality in Europe. H. pylori prevalence in the present studies differs very widely as reflected in the individual study regions. The median prevalence in Europe is 39% among doctors performing gastroscopies and 37% for their assistants. In contrast and somewhat surprisingly, the prevalence among non-medical control groups (studies N = 8) is 45%, in contrast with the 35% prevalence among medical controls (studies N = 7). The prevalence among doctors and nurses in Asia is significantly higher by comparison (median 68% and 78% respectively), whereas among the control groups it is considerably lower (both 35%). There is also a clear difference between target population and controls in the studies from America/Australia, albeit at a much lower level - doctors 52%, assistants 18%, non-medical controls 16%, medical controls 29%. The different H. pylori prevalence rates of the general population in different regions (Asia 50-80%, Europe 30-50%, North America 30% [3]) corroborate the findings in the non-medical controls. However, why the present studies from Europe found a higher prevalence among non-medical controls than among gastroenterological personnel remains obscure.
Table 4
Regional distribution of studies
Study
area
Number
studies
Quality
Gastro staff
(HP positive %)
Doctors
(HP positive %)
Assistants
(HP positive %)
Non-medical controls
(HP positive %)
Medical controls
(HP positive %)
Europe
 
10
all
1303 (37)
1417 (39)
288 (37)
1623 (45)
1311 (35)
 
6
good
1183 (37)
1228 (39)
288 (37)
822 (33)
931 (35)
 
4
moderate
120 (46)
189 (43)
 
801 (53)
380 (35)
America / Australia
 
7
all
481 (31)
204 (52)
335 (18)
1929 (16)
35 (29)
 
3
good
268 (42)
150 (61)
256 (17)
895 (16)
 
 
4
moderate
213 (31)
54 (42)
79 (19)
1034 (16)
35 (29)
Asia
       
 
7
all
596 (73)
445 (68)
186 (78)
5557 (35)
204 (35)
 
6
good
596 (73)
428 (70)
186 (78)
5522 (45)
187 (52)
 
1
moderate
 
17 (29)
 
35 (20)
17 (18)
Gastro staff = gastroenterological staff

Diagnostic method

In epidemiological studies, a H. pylori infection is mainly diagnosed by non-invasive methods such as serology or breath tests. More rarely, a stool antigen test is used. In the present studies this method was used to ascertain prevalence in only one study. In contrast, 16 studies used serological tests and seven used breath tests. After stratification by diagnostic method, the meta-analysis showed no differences in risk. The main advantage of serology is that it is a quick, low-cost method for use with large study populations. Nonetheless, this method has various limitations. These relate in part to defining a cut-off value to differentiate between positive and negative results and to the sensitivity of the test to changes in reagents and laboratory conditions, which is particularly relevant in longitudinal studies and repeat examinations. The breath test (C13-UBT) is somewhat more cost-intensive, but its sensitivity and specificity are in the order of 90-95%, and this method is just as suitable as the stool test, particularly when examining children [49, 50].

Comparison with other studies

Since the H. pylori bacterium was discovered, numerous reviews have been published on the subject. Some dealt with the occupational risk of infection run by medical personnel in general, while some examined gastroenterological personnel in particular. Matysiak-Budnik [51] showed an association between occupational exposure and an increased risk of infection. Williams [20], too, stated that there were increased occupational risks for endoscopy personnel. However, the evidence in this review appears contradictory, since the findings varied between no risk and a five times greater risk. De Schryver et al. [21, 22] were able to show in their reviews increased risks for gastroenterologists and endoscopy personnel. Magalhaes Queiroz [52] found controversial data on the occupational risk, but they considered only some of the studies also included here for gastroenterological personnel.

Strength and limitations of the review

To our knowledge, this is the only meta-analysis to date to focus on the prevalence of H. pylori infection among endoscopy personnel. The strengths of this work are those of a meta-analysis. A meta-analysis can give a comprehensive overview of the state of research. Pooling different studies on a topic increases statistical power and validity in comparison with smaller individual studies and increases the likelihood of being able to identify actual differences that exist between groups [53]. Nonetheless, this form of study also has limitations, and the result of the effect estimate can only be considered and interpreted in relation to the underlying data. One problem in this paper is the statistical heterogeneity among studies. This was taken into account first by applying the random effect model. In addition, sub-group analyses were carried out so that only studies with identical characteristics were pooled and analysed [23].
The search strategy to listed papers might introduce publication bias, because inconclusive studies might be less likely published in listed journals. However, we controlled for publication bias and found no evidence for it.
An adequate control for confounding is crucial in occupational infectious disease epidemiology, especially when transmission of infection mainly occurs in childhood. Therefore, for a study to be classified as good, it needed to give the confounding nature of age and social status due consideration. However, the control for significant confounders via selection of the control group or by adjustment could not be assessed for effectiveness.
Although the assessment of study quality was taken into account, further criteria must be heeded when pooling and calculating pooled estimates - differences in risk factors, in the observance or adjustment of confounders, and in the study population (different regions, different survey dates, different study approaches/control groups). A lack of information about age, gender, ethnicity and work-related factors, such as the use of gloves and masks or the frequency of gastroscopies performed, precludes more differentiated analyses.

Conclusions

Gastroenterological personnel are exposed to an increased risk of H. pylori infection. Further studies involving suitable control groups and designed as prospectively as possible should identify the precise risk.

Acknowledgements

We wish to thank Dana Wendeler (BGW) for her support with the management of the literature. The study was conducted by the Institute for Health Service Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, with funding support from the Institution of Statutory Accident Insurance of the Health and Welfare Services (BGW). The BGW did not influence the study question or design, nor did it alter the analysis or interpretation of the results.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

AS made substantial contributions to the design of the study and to the extraction and interpretation of data. She was involved in the drafting of the major scientific content in the manuscript. MH made substantial contributions to the analysis and interpretation of the data. She was involved in proofreading and editing the scientific content of the manuscript. CW made substantial contributions to the design of the study. She was involved in proofreading and editing the scientific content of the manuscript. JTC made substantial contributions to the interpretation of data and was involved in revising the manuscript critically for important intellectual content. AN made substantial contributions to the design and to the extraction and interpretation of data. He was involved in drafting the manuscript. CP made substantial contributions to the design of the study, the extraction of data, and to the analysis and interpretation of data. She was involved in drafting the manuscript. All authors confirm that they have seen and approved the final version and have no conflicts of interest.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Guarner J: The spectrum of gastric disease associated with Helicobacter pylori and other infectious gastritides. Curr Gastroenterol Rep. 2004, 6: 441-446. 10.1007/s11894-004-0065-7.CrossRefPubMed Guarner J: The spectrum of gastric disease associated with Helicobacter pylori and other infectious gastritides. Curr Gastroenterol Rep. 2004, 6: 441-446. 10.1007/s11894-004-0065-7.CrossRefPubMed
2.
Zurück zum Zitat Mitchell HM: The epidemiology of Helicobacter pylori. Curr Top Microbiol Immunol. 1999, 241: 11-30.PubMed Mitchell HM: The epidemiology of Helicobacter pylori. Curr Top Microbiol Immunol. 1999, 241: 11-30.PubMed
3.
Zurück zum Zitat Mandeville KL, Krabshuis J, Ladep NG, Mulder CJ, Quigley EM, Khan SA: Gastroenterology in developing countries: issues and advances. World J Gastroenterol. 2009, 15: 2839-2854. 10.3748/wjg.15.2839.CrossRefPubMedPubMedCentral Mandeville KL, Krabshuis J, Ladep NG, Mulder CJ, Quigley EM, Khan SA: Gastroenterology in developing countries: issues and advances. World J Gastroenterol. 2009, 15: 2839-2854. 10.3748/wjg.15.2839.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Seher C, Thierfelder W, Dortschy R: Helicobacter pylori--prevalence in the German population. Gesundheitswesen. 2000, 62: 569-603.CrossRef Seher C, Thierfelder W, Dortschy R: Helicobacter pylori--prevalence in the German population. Gesundheitswesen. 2000, 62: 569-603.CrossRef
5.
Zurück zum Zitat Grimm W, Fischbach W: [Helicobacter pylori infection in children and juveniles: an epidemiological study on prevalence, socio-economic factors and symptoms]. Dtsch Med Wochenschr. 2003, 128: 1878-1883.CrossRefPubMed Grimm W, Fischbach W: [Helicobacter pylori infection in children and juveniles: an epidemiological study on prevalence, socio-economic factors and symptoms]. Dtsch Med Wochenschr. 2003, 128: 1878-1883.CrossRefPubMed
6.
Zurück zum Zitat Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984, 1: 1311-1315.CrossRefPubMed Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984, 1: 1311-1315.CrossRefPubMed
7.
Zurück zum Zitat Everhart JE: Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am. 2000, 29: 559-578. 10.1016/S0889-8553(05)70130-8.CrossRefPubMed Everhart JE: Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am. 2000, 29: 559-578. 10.1016/S0889-8553(05)70130-8.CrossRefPubMed
8.
Zurück zum Zitat Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stumer T: Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer. 2002, 98: 446-449. 10.1002/ijc.10201.CrossRefPubMed Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stumer T: Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer. 2002, 98: 446-449. 10.1002/ijc.10201.CrossRefPubMed
9.
Zurück zum Zitat Moayyedi P, Axon AT, Feltbower R, Duffett S, Crocombe W, Braunholtz D, et al: Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol. 2002, 31: 624-631. 10.1093/ije/31.3.624.CrossRefPubMed Moayyedi P, Axon AT, Feltbower R, Duffett S, Crocombe W, Braunholtz D, et al: Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol. 2002, 31: 624-631. 10.1093/ije/31.3.624.CrossRefPubMed
10.
Zurück zum Zitat Makristathis A, Pasching E, Schutze K, Wimmer M, Rotter ML, Hirschl AM: Detection of Helicobacter pylori in stool specimens by PCR and antigen enzyme immunoassay. J Clin Microbiol. 1998, 36: 2772-2774.PubMedPubMedCentral Makristathis A, Pasching E, Schutze K, Wimmer M, Rotter ML, Hirschl AM: Detection of Helicobacter pylori in stool specimens by PCR and antigen enzyme immunoassay. J Clin Microbiol. 1998, 36: 2772-2774.PubMedPubMedCentral
11.
Zurück zum Zitat Banatvala N, Lopez CR, Owen R, Abdi Y, Davies G, Hardie J, et al: Helicobacter pylori in dental plaque. Lancet. 1993, 341: 380-CrossRefPubMed Banatvala N, Lopez CR, Owen R, Abdi Y, Davies G, Hardie J, et al: Helicobacter pylori in dental plaque. Lancet. 1993, 341: 380-CrossRefPubMed
12.
Zurück zum Zitat Dowsett SA, Kowolik MJ: Oral Helicobacter pylori: can we stomach it?. Crit Rev Oral Biol Med. 2003, 14: 226-233. 10.1177/154411130301400307.CrossRefPubMed Dowsett SA, Kowolik MJ: Oral Helicobacter pylori: can we stomach it?. Crit Rev Oral Biol Med. 2003, 14: 226-233. 10.1177/154411130301400307.CrossRefPubMed
13.
Zurück zum Zitat Luman W, Zhao Y, Ng HS, Ling KL: Helicobacter pylori infection is unlikely to be transmitted between partners: evidence from genotypic study in partners of infected patients. Eur J Gastroenterol Hepatol. 2002, 14: 521-528. 10.1097/00042737-200205000-00009.CrossRefPubMed Luman W, Zhao Y, Ng HS, Ling KL: Helicobacter pylori infection is unlikely to be transmitted between partners: evidence from genotypic study in partners of infected patients. Eur J Gastroenterol Hepatol. 2002, 14: 521-528. 10.1097/00042737-200205000-00009.CrossRefPubMed
14.
Zurück zum Zitat Matsuda R, Morizane T: Helicobacter pylori infection in dental professionals: a 6-year prospective study. Helicobacter. 2005, 10: 307-311. 10.1111/j.1523-5378.2005.00321.x.CrossRefPubMed Matsuda R, Morizane T: Helicobacter pylori infection in dental professionals: a 6-year prospective study. Helicobacter. 2005, 10: 307-311. 10.1111/j.1523-5378.2005.00321.x.CrossRefPubMed
15.
Zurück zum Zitat Lin SK, Lambert JR, Schembri MA, Nicholson L, Johnson IH: The prevalence of Helicobacter pylori in practising dental staff and dental students. Aust Dent J. 1998, 43: 35-39. 10.1111/j.1834-7819.1998.tb00150.x.CrossRefPubMed Lin SK, Lambert JR, Schembri MA, Nicholson L, Johnson IH: The prevalence of Helicobacter pylori in practising dental staff and dental students. Aust Dent J. 1998, 43: 35-39. 10.1111/j.1834-7819.1998.tb00150.x.CrossRefPubMed
16.
Zurück zum Zitat Loster BW, Czesnikiewicz-Guzik M, Bielanski W, Karczewska E, Loster JE, Kalukin J, et al: Prevalence and characterization of Helicobacter pylori (H. pylori) infection and colonization in dentists. J Physiol Pharmacol. 2009, 60 (Suppl 8): 13-18.PubMed Loster BW, Czesnikiewicz-Guzik M, Bielanski W, Karczewska E, Loster JE, Kalukin J, et al: Prevalence and characterization of Helicobacter pylori (H. pylori) infection and colonization in dentists. J Physiol Pharmacol. 2009, 60 (Suppl 8): 13-18.PubMed
17.
Zurück zum Zitat de Schryver A, Cornelis K, Van Winckel M, Moens G, Devlies G, Derthoo D, et al: The occupational risk of Helicobacter pylori infection among workers in institutions for people with intellectual disability. Occup Environ Med. 2008, 65: 587-591. 10.1136/oem.2007.035022.CrossRefPubMed de Schryver A, Cornelis K, Van Winckel M, Moens G, Devlies G, Derthoo D, et al: The occupational risk of Helicobacter pylori infection among workers in institutions for people with intellectual disability. Occup Environ Med. 2008, 65: 587-591. 10.1136/oem.2007.035022.CrossRefPubMed
18.
Zurück zum Zitat Nurnberg M, Schulz HJ, Ruden H, Vogt K: Do conventional cleaning and disinfection techniques avoid the risk of endoscopic Helicobacter pylori transmission?. Endoscopy. 2003, 35: 295-299. 10.1055/s-2003-38149.CrossRefPubMed Nurnberg M, Schulz HJ, Ruden H, Vogt K: Do conventional cleaning and disinfection techniques avoid the risk of endoscopic Helicobacter pylori transmission?. Endoscopy. 2003, 35: 295-299. 10.1055/s-2003-38149.CrossRefPubMed
19.
Zurück zum Zitat Wu MS, Wang JT, Yang JC, Wang HH, Sheu JC, Chen DS, et al: Effective reduction of Helicobacter pylori infection after upper gastrointestinal endoscopy by mechanical washing of the endoscope. Hepatogastroenterology. 1996, 43: 1660-1664.PubMed Wu MS, Wang JT, Yang JC, Wang HH, Sheu JC, Chen DS, et al: Effective reduction of Helicobacter pylori infection after upper gastrointestinal endoscopy by mechanical washing of the endoscope. Hepatogastroenterology. 1996, 43: 1660-1664.PubMed
20.
Zurück zum Zitat Williams CL: Helicobacter pylori and endoscopy. J Hosp Infect. 1999, 41: 263-268. 10.1053/jhin.1998.0538.CrossRefPubMed Williams CL: Helicobacter pylori and endoscopy. J Hosp Infect. 1999, 41: 263-268. 10.1053/jhin.1998.0538.CrossRefPubMed
21.
Zurück zum Zitat De Schryver AA, Van Winckel MA: Helicobacter pylori infection: epidemiology and occupational risk for health care workers. Ann Acad Med Singapore. 2001, 30: 457-463.PubMed De Schryver AA, Van Winckel MA: Helicobacter pylori infection: epidemiology and occupational risk for health care workers. Ann Acad Med Singapore. 2001, 30: 457-463.PubMed
22.
Zurück zum Zitat De Schryver AA, Van Hooste WL, Van Winckel MA, Van Sprundel MP: Helicobacter pylori infection: a global occupational risk for healthcare workers?. Int J Occup Environ Health. 2004, 10: 428-432.CrossRefPubMed De Schryver AA, Van Hooste WL, Van Winckel MA, Van Sprundel MP: Helicobacter pylori infection: a global occupational risk for healthcare workers?. Int J Occup Environ Health. 2004, 10: 428-432.CrossRefPubMed
23.
Zurück zum Zitat Higgins JPT, Green S: Cochran Handbook for Systematic Reviews of Interventions 5.0.2. 2009, The Cochran Collaboration, updated September 2009 Higgins JPT, Green S: Cochran Handbook for Systematic Reviews of Interventions 5.0.2. 2009, The Cochran Collaboration, updated September 2009
25.
Zurück zum Zitat Mastromarino P, Conti C, Donato K, Strappini PM, Cattaruzza MS, Orsi GB: Does hospital work constitute a risk factor for Helicobacter pylori infection?. J Hosp Infect. 2005, 60: 261-268. 10.1016/j.jhin.2004.12.019.CrossRefPubMed Mastromarino P, Conti C, Donato K, Strappini PM, Cattaruzza MS, Orsi GB: Does hospital work constitute a risk factor for Helicobacter pylori infection?. J Hosp Infect. 2005, 60: 261-268. 10.1016/j.jhin.2004.12.019.CrossRefPubMed
26.
Zurück zum Zitat Birkenfeld S, Keter D, Dikman R, Shevah O, Shirin H, Niv Y: Prevalence of Helicobacter pylori infection in health-care personnel of primary care and gastroenterology clinics. J Clin Gastroenterol. 2004, 38: 19-23. 10.1097/00004836-200401000-00006.CrossRefPubMed Birkenfeld S, Keter D, Dikman R, Shevah O, Shirin H, Niv Y: Prevalence of Helicobacter pylori infection in health-care personnel of primary care and gastroenterology clinics. J Clin Gastroenterol. 2004, 38: 19-23. 10.1097/00004836-200401000-00006.CrossRefPubMed
27.
Zurück zum Zitat Hildebrand P, Meyer-Wyss BM, Mossi S, Beglinger C: Risk among gastroenterologists of acquiring Helicobacter pylori infection: case-control study. BMJ. 2000, 321: 149-10.1136/bmj.321.7254.149.CrossRefPubMedPubMedCentral Hildebrand P, Meyer-Wyss BM, Mossi S, Beglinger C: Risk among gastroenterologists of acquiring Helicobacter pylori infection: case-control study. BMJ. 2000, 321: 149-10.1136/bmj.321.7254.149.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ellett ML, Lou Q, Chong SK: Prevalence of immunoglobulin G to Helicobacter pylori among endoscopy nurses/technicians. Gastroenterol Nurs. 1999, 22: 3-6. 10.1097/00001610-199901000-00002.CrossRefPubMed Ellett ML, Lou Q, Chong SK: Prevalence of immunoglobulin G to Helicobacter pylori among endoscopy nurses/technicians. Gastroenterol Nurs. 1999, 22: 3-6. 10.1097/00001610-199901000-00002.CrossRefPubMed
29.
Zurück zum Zitat Mones J, Martin-de-Argila C, Samitier RS, Gisbert JP, Sainz S, Boixeda D: Prevalence of Helicobacter pylori infection in medical professionals in Spain. Eur J Gastroenterol Hepatol. 1999, 11: 239-242. 10.1097/00042737-199903000-00005.CrossRefPubMed Mones J, Martin-de-Argila C, Samitier RS, Gisbert JP, Sainz S, Boixeda D: Prevalence of Helicobacter pylori infection in medical professionals in Spain. Eur J Gastroenterol Hepatol. 1999, 11: 239-242. 10.1097/00042737-199903000-00005.CrossRefPubMed
30.
Zurück zum Zitat Abbas Z, Jafri W, Khan AH, Shah MA: Prevalence of Helicobacter pylori antibodies in endoscopy personnel and non-medical volunteers of Karachi. J Pak Med Assoc. 1998, 48: 201-203.PubMed Abbas Z, Jafri W, Khan AH, Shah MA: Prevalence of Helicobacter pylori antibodies in endoscopy personnel and non-medical volunteers of Karachi. J Pak Med Assoc. 1998, 48: 201-203.PubMed
31.
Zurück zum Zitat Nishikawa J, Kawai H, Takahashi A, Seki T, Yoshikawa N, Akita Y, et al: Seroprevalence of immunoglobulin G antibodies against Helicobacter pylori among endoscopy personnel in Japan. Gastrointest Endosc. 1998, 48: 237-243. 10.1016/S0016-5107(98)70184-1.CrossRefPubMed Nishikawa J, Kawai H, Takahashi A, Seki T, Yoshikawa N, Akita Y, et al: Seroprevalence of immunoglobulin G antibodies against Helicobacter pylori among endoscopy personnel in Japan. Gastrointest Endosc. 1998, 48: 237-243. 10.1016/S0016-5107(98)70184-1.CrossRefPubMed
32.
Zurück zum Zitat Braden B, Duan LP, Caspary WF, Lembcke B: Endoscopy is not a risk factor for Helicobacter pylori infection--but medical practice is. Gastrointest Endosc. 1997, 46: 305-310. 10.1016/S0016-5107(97)70115-9.CrossRefPubMed Braden B, Duan LP, Caspary WF, Lembcke B: Endoscopy is not a risk factor for Helicobacter pylori infection--but medical practice is. Gastrointest Endosc. 1997, 46: 305-310. 10.1016/S0016-5107(97)70115-9.CrossRefPubMed
33.
Zurück zum Zitat Goh KL, Parasakthi N, Ong KK: Prevalence of Helicobacter pylori infection in endoscopy and non-endoscopy personnel: results of field survey with serology and 14C-urea breath test. Am J Gastroenterol. 1996, 91: 268-270.PubMed Goh KL, Parasakthi N, Ong KK: Prevalence of Helicobacter pylori infection in endoscopy and non-endoscopy personnel: results of field survey with serology and 14C-urea breath test. Am J Gastroenterol. 1996, 91: 268-270.PubMed
34.
Zurück zum Zitat Liu WZ, Xiao SD, Jiang SJ, Li RR, Pang ZJ: Seroprevalence of Helicobacter pylori infection in medical staff in Shanghai. Scand J Gastroenterol. 1996, 31: 749-752. 10.3109/00365529609010346.CrossRefPubMed Liu WZ, Xiao SD, Jiang SJ, Li RR, Pang ZJ: Seroprevalence of Helicobacter pylori infection in medical staff in Shanghai. Scand J Gastroenterol. 1996, 31: 749-752. 10.3109/00365529609010346.CrossRefPubMed
35.
Zurück zum Zitat Chong J, Marshall BJ, Barkin JS, McCallum RW, Reiner DK, Hoffman SR, et al: Occupational exposure to Helicobacter pylori for the endoscopy professional: a sera epidemiological study. Am J Gastroenterol. 1994, 89: 1987-1992.PubMed Chong J, Marshall BJ, Barkin JS, McCallum RW, Reiner DK, Hoffman SR, et al: Occupational exposure to Helicobacter pylori for the endoscopy professional: a sera epidemiological study. Am J Gastroenterol. 1994, 89: 1987-1992.PubMed
36.
Zurück zum Zitat Lin SK, Lambert JR, Schembri MA, Nicholson L, Korman MG: Helicobacter pylori prevalence in endoscopy and medical staff. J Gastroenterol Hepatol. 1994, 9: 319-324. 10.1111/j.1440-1746.1994.tb01249.x.CrossRefPubMed Lin SK, Lambert JR, Schembri MA, Nicholson L, Korman MG: Helicobacter pylori prevalence in endoscopy and medical staff. J Gastroenterol Hepatol. 1994, 9: 319-324. 10.1111/j.1440-1746.1994.tb01249.x.CrossRefPubMed
37.
Zurück zum Zitat Velasco Elizalde C, Fernandez Ferrer MA, Rodriguez Muniz N: [Serologic diagnosis of Helicobacter pylori in endoscopy personnel. Serology in endoscopists]. Rev Esp Enferm Dig. 2007, 99: 88-93.CrossRefPubMed Velasco Elizalde C, Fernandez Ferrer MA, Rodriguez Muniz N: [Serologic diagnosis of Helicobacter pylori in endoscopy personnel. Serology in endoscopists]. Rev Esp Enferm Dig. 2007, 99: 88-93.CrossRefPubMed
38.
Zurück zum Zitat Pronai L, Schandl L, Tulassay Z: Prevalence of Helicobacter pylori infection in Hungarian gastroenterologists and general practitioners. Eur J Gastroenterol Hepatol. 2000, 12: 473-474. 10.1097/00042737-200012040-00018.CrossRefPubMed Pronai L, Schandl L, Tulassay Z: Prevalence of Helicobacter pylori infection in Hungarian gastroenterologists and general practitioners. Eur J Gastroenterol Hepatol. 2000, 12: 473-474. 10.1097/00042737-200012040-00018.CrossRefPubMed
39.
Zurück zum Zitat Kamat AH, Mehta PR, Bhatia SJ, Koppikar GV: Seroprevalence of IgG antibodies to Helicobacter pylori among gastrointestinal endoscopists, radiologists and paramedical personnel. J Assoc Physicians India. 1999, 47: 866-868.PubMed Kamat AH, Mehta PR, Bhatia SJ, Koppikar GV: Seroprevalence of IgG antibodies to Helicobacter pylori among gastrointestinal endoscopists, radiologists and paramedical personnel. J Assoc Physicians India. 1999, 47: 866-868.PubMed
40.
Zurück zum Zitat Rudi J, Toppe H, Marx N, Zuna I, Theilmann L, Stremmel W, et al: Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Am J Gastroenterol. 1997, 92: 258-262.PubMed Rudi J, Toppe H, Marx N, Zuna I, Theilmann L, Stremmel W, et al: Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Am J Gastroenterol. 1997, 92: 258-262.PubMed
41.
Zurück zum Zitat Pristautz H, Eherer A, Brezinschek R, Truschnig-Wilders M, Petritsch W, Schreiber F, et al: Prevalence of Helicobacter pylori antibodies in the serum of gastroenterologists in Austria. Endoscopy. 1994, 26: 690-696. 10.1055/s-2007-1009067.CrossRefPubMed Pristautz H, Eherer A, Brezinschek R, Truschnig-Wilders M, Petritsch W, Schreiber F, et al: Prevalence of Helicobacter pylori antibodies in the serum of gastroenterologists in Austria. Endoscopy. 1994, 26: 690-696. 10.1055/s-2007-1009067.CrossRefPubMed
42.
Zurück zum Zitat Mitchell HM, Lee A, Carrick J: Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori. Scand J Gastroenterol. 1989, 24: 396-400. 10.3109/00365528909093065.CrossRefPubMed Mitchell HM, Lee A, Carrick J: Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori. Scand J Gastroenterol. 1989, 24: 396-400. 10.3109/00365528909093065.CrossRefPubMed
43.
Zurück zum Zitat Reiff A, Jacobs E, Kist M: Seroepidemiological study of the immune response to Campylobacter pylori in potential risk groups. Eur J Clin Microbiol Infect Dis. 1989, 8: 592-596. 10.1007/BF01968135.CrossRefPubMed Reiff A, Jacobs E, Kist M: Seroepidemiological study of the immune response to Campylobacter pylori in potential risk groups. Eur J Clin Microbiol Infect Dis. 1989, 8: 592-596. 10.1007/BF01968135.CrossRefPubMed
44.
Zurück zum Zitat Rawles JW, Harris ML, Paull G, Dick J, Yardley JH, Hendrix TR, et al: Antibody to Campylobacter pyloridis in endoscopy personnel, patients and controls. Abstr Pap. 1987, 92: 1589- Rawles JW, Harris ML, Paull G, Dick J, Yardley JH, Hendrix TR, et al: Antibody to Campylobacter pyloridis in endoscopy personnel, patients and controls. Abstr Pap. 1987, 92: 1589-
45.
Zurück zum Zitat Morris A, Lloyd G, Nicholson G: Campylobacter pyloridis serology among gastroendoscopy clinic staff. N Z Med J. 1986, 99: 819-820. Morris A, Lloyd G, Nicholson G: Campylobacter pyloridis serology among gastroendoscopy clinic staff. N Z Med J. 1986, 99: 819-820.
46.
Zurück zum Zitat Noone PA, Waclawski ER, Watt AD: Are endoscopy nurses at risk of infection with Helicobacter pylori from their work?. Occup Med (Lond). 2006, 56: 122-128.CrossRef Noone PA, Waclawski ER, Watt AD: Are endoscopy nurses at risk of infection with Helicobacter pylori from their work?. Occup Med (Lond). 2006, 56: 122-128.CrossRef
47.
Zurück zum Zitat Potts LF, Lewis SJ, Mountford RA: Prevalence of Helicobacter pylori in respiratory physicians performing bronchoscopy: a comparison with gastroenterologists using the carbon 13 urea breath test. Helicobacter. 1997, 2: 152-154. 10.1111/j.1523-5378.1997.tb00078.x.CrossRefPubMed Potts LF, Lewis SJ, Mountford RA: Prevalence of Helicobacter pylori in respiratory physicians performing bronchoscopy: a comparison with gastroenterologists using the carbon 13 urea breath test. Helicobacter. 1997, 2: 152-154. 10.1111/j.1523-5378.1997.tb00078.x.CrossRefPubMed
48.
Zurück zum Zitat Su YC, Wang WM, Chen LT, Chiang W, Chen CY, Lu SN, et al: High seroprevalence of IgG against Helicobacter pylori among endoscopists in Taiwan. Dig Dis Sci. 1996, 41: 1571-1576. 10.1007/BF02087902.CrossRefPubMed Su YC, Wang WM, Chen LT, Chiang W, Chen CY, Lu SN, et al: High seroprevalence of IgG against Helicobacter pylori among endoscopists in Taiwan. Dig Dis Sci. 1996, 41: 1571-1576. 10.1007/BF02087902.CrossRefPubMed
49.
Zurück zum Zitat Brown LM: Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000, 22: 283-297.CrossRefPubMed Brown LM: Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000, 22: 283-297.CrossRefPubMed
50.
Zurück zum Zitat Logan RP, Walker MM: ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection. BMJ. 2001, 323: 920-922. 10.1136/bmj.323.7318.920.CrossRefPubMedPubMedCentral Logan RP, Walker MM: ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection. BMJ. 2001, 323: 920-922. 10.1136/bmj.323.7318.920.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Matysiak-Budnik T, Megraud F: Epidemiology of Helicobacter pylori infection with special reference to professional risk. J Physiol Pharmacol. 1997, 48 (Suppl 4): 3-17.PubMed Matysiak-Budnik T, Megraud F: Epidemiology of Helicobacter pylori infection with special reference to professional risk. J Physiol Pharmacol. 1997, 48 (Suppl 4): 3-17.PubMed
52.
Zurück zum Zitat Magalhaes Queiroz DM, Luzza F: Epidemiology of Helicobacter pylori infection. Helicobacter. 2006, 11 (Suppl 1): 1-5.CrossRefPubMed Magalhaes Queiroz DM, Luzza F: Epidemiology of Helicobacter pylori infection. Helicobacter. 2006, 11 (Suppl 1): 1-5.CrossRefPubMed
53.
Zurück zum Zitat Ressing M, Blettner M, Klug SJ: Systematische Übersichtsarbeiten und Metaanalysen: Teil 6 der Serie zur Bewertung wissenschaftlicher Publikationen. Dtsch Arztebl. 2009, 106: 456-463. Ressing M, Blettner M, Klug SJ: Systematische Übersichtsarbeiten und Metaanalysen: Teil 6 der Serie zur Bewertung wissenschaftlicher Publikationen. Dtsch Arztebl. 2009, 106: 456-463.
Metadaten
Titel
The occupational risk of Helicobacter pyloriinfection among gastroenterologists and their assistants
verfasst von
Claudia Peters
Anja Schablon
Melanie Harling
Claudia Wohlert
José Torres Costa
Albert Nienhaus
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2011
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-154

Weitere Artikel der Ausgabe 1/2011

BMC Infectious Diseases 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.